NCT02944526View on ClinicalTrials.gov

The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 16, 2020

Study Completion Date

September 30, 2020

Conditions
Adhesive CapsulitisFrozen ShoulderNerve Block
Interventions
DRUG

Ropivacaine Monohydrochloride

Suprascapular nerve block under ultrasound control: injection of 5ml Ropivacaine HCL 2mg /ml

DRUG

Placebo - Concentrate

Placebo suprascapular nerve block under ultrasound control: injection of 5ml physiological / isotonic saline

Trial Locations (1)

1090

Marc Schiltz, MD, Brussels

All Listed Sponsors
collaborator

University Hospital St Luc, Brussels

OTHER

lead

Clinique Saint-Jean, Bruxelles

OTHER

NCT02944526 - The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter